U.S. Luxury Stock News

With no single headline event driving attention today, JBS (NYSE:JBS) is drawing interest as investors look at its recent share moves and its sizeable global meat processing footprint across beef, pork, poultry, and prepared foods. See our latest analysis for JBS. JBS’s recent 7 day share price return of 13.01% and 90 day share price return of 17.53%, with the stock now at $17.03, suggest momentum has picked up after a quieter 30 day share price return of 0.83%. If the JBS move has you...

Hawaiian Electric Industries (NYSE:HE) has agreed to a $100 million settlement to resolve significant stockholder derivative lawsuits. The payment will be funded by insurers and also partially settles a related securities class action. The agreement is subject to final court approval, with upcoming hearings expected to clarify the remaining legal process. For shareholders watching NYSE:HE at a current share price of $14.67, this settlement addresses a key source of legal uncertainty. The...

Curious if Union Pacific at around US$238.79 is offering fair value or a margin of safety right now? This article walks through the key numbers that matter for you. The stock has seen mixed returns recently, with a 0.2% move over the last 7 days, a 9.9% decline over 30 days, gains of 3.0% year to date and 3.5% over the last year, and gains of 28.2% over 3 years and 19.6% over 5 years. Recent coverage of Union Pacific has focused on its role as a major U.S. railroad operator and how broader...

Xcel Energy (NasdaqGS:XEL) has filed new regulatory materials with the Federal Energy Regulatory Commission focused on dam safety and compliance. The company’s recent correspondence covers dam stability, embankment integrity, and landslide monitoring at its hydro-related facilities. These filings outline ongoing safety measures and responses to federal oversight of critical infrastructure. Xcel Energy, a regulated electric and natural gas utility, depends on reliable generation and...

For readers wondering whether Smithfield Foods at US$26.69 still offers value, or if the easy gains are already behind it, this article breaks down what the current price might be implying. The stock has returned 13.7% over the past week, 7.3% over the last month, 20.5% year to date, and 36.9% over the past year, which naturally raises questions about how expectations and risk are now being priced in. Recent coverage around Smithfield Foods has focused on its positioning within the food...

If you are wondering whether Viavi Solutions at US$34.64 is still attractively priced after a big run, the key question is what that price actually reflects about the business. The stock has delivered returns of 3.1% over the past week, 16.6% over the past month, 90.9% year to date and 209.6% over the last year, with a 225.3% return over three years and 114.0% over five years, which puts recent valuation questions front and center. Recent coverage has focused on Viavi Solutions as a...

The Public Service Commission of South Carolina has approved Duke Energy’s plan to build an approximately 1,365 MW high-efficiency natural gas plant in Anderson County, with construction targeted to start in 2027 and operations by early 2031, following an extensive public review and community engagement process. This facility, expected to support more than 2,200 jobs annually during construction and deliver an estimated US$84 million in yearly statewide economic impact once operational, also...

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

In the past week, Best Buy reported quarterly results showing adjusted EPS of US$2.61, up 1.2% year over year, alongside a 0.8% decline in comparable sales and slightly softer-than-expected revenue, while also announcing a 1% increase in its quarterly dividend to US$0.96 per share. Management’s decision to raise the dividend and emphasize scalable profit drivers such as its digital Marketplace and Best Buy Ads highlights a focus on recurring, higher-margin revenue streams even as top-line...

In late March 2026, Paychex reported third-quarter revenue of US$1,808.9 million and net income of US$560.3 million, alongside updates on completing two share repurchase authorizations totaling US$400 million and US$352.22 million, and highlighted its cybersecurity focus ahead of an RSA Conference presentation. While revenue and quarterly earnings per share increased year over year, nine-month net income and EPS were slightly lower, underscoring that growth in sales has not yet translated...

If you are wondering whether Cal-Maine Foods at around US$77.12 is pricing in too much optimism or leaving some value on the table, a closer look at its valuation can help frame that question. The share price is near US$77.12 after a 0.1% move over the last 7 days, with an 11.5% decline over 30 days, a 1.7% decline year to date, a 7.8% decline over 1 year, but a 53.8% gain over 3 years and a 159.0% gain over 5 years. Recent coverage has focused on Cal-Maine Foods as a key player in the US...

CDW stock performance context CDW (CDW) has drawn attention after a period where the share price shows a 2.5% decline over the past day and negative returns over the week, month, past 3 months, year to date, and past year. See our latest analysis for CDW. At a share price of $118.17, CDW’s recent 1 day share price decline of 2.5% sits within a broader period of weaker momentum, with a 1 year total shareholder return of 25.0% in the red. This may reflect cooler sentiment around its risk and...

If you are wondering whether lululemon athletica's current share price really reflects what the business is worth, starting with a clear look at valuation can help you frame that question properly. The stock last closed at US$145.85, with returns of an 11.3% decline over 7 days, a 21.2% decline over 30 days, a 30.8% decline year to date, and a 48.5% decline over the past year, which has likely shifted how many investors think about its potential and risk. Recent headlines around lululemon...

For readers wondering whether Indivior Pharmaceuticals at around US$28.97 is still a good entry point or more of a hold after such a big run, this article focuses squarely on what the current valuation is indicating. The stock has pulled back, with a 1.4% decline over the last 7 days, an 11.5% decline over 30 days, and an 18.9% decline year to date. This follows a very strong 204.0% return over 1 year and 216.6% over 5 years. Recent attention around Indivior Pharmaceuticals has centered on...

Over the past year, Agnico Eagle Mines has seen substantial insider selling, including about US$16,000,000 of stock offloaded in the last quarter with no corresponding insider purchases, and the largest single sale coming from CEO Ammar Al-Joundi at a price below where the shares trade today. This pattern of executives reducing their holdings without any offsetting buys may raise questions for investors about how insiders currently view the company’s valuation. Next, we’ll examine how this...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Morningstar...

Electronic Arts (NasdaqGS:EA) has completed a multi billion dollar private equity takeover, reshaping its ownership structure. JPMorgan Chase & Co. arranged complex financing to close the leveraged buyout in challenging market conditions. Management is highlighting plans to use artificial intelligence to drive the next phase of the company’s growth focus. For investors watching NasdaqGS:EA, the completed deal comes with the stock at $202.01 and a 1 year return of 40.4%. Over 3 years, the...

Cardinal Health recently announced that Patricia A. Hemingway Hall has succeeded Gregory B. Kenny as Chair of the Board following his retirement on March 23, 2026, after his long tenure guiding the company through portfolio changes and operational improvement efforts. Hemingway Hall’s elevation to Chair brings the perspective of a former health insurer CEO and long-serving governance leader at Cardinal Health, potentially shaping how the company approaches healthcare partnerships and...

What stands out about Stock Yards Bancorp right now Stock Yards Bancorp (SYBT) has drawn attention after recent trading left the shares around $63.91, with returns showing small single digit moves over the past week, month, and past 3 months. See our latest analysis for Stock Yards Bancorp. While the 1 day share price return of 2.31% and year to date share price return of 1.98% are both negative, the 3 year total shareholder return of 24.86% and 5 year total shareholder return of 37.15%...

Amylyx Pharmaceuticals (AMLX) drew fresh attention after announcing that the last participant in its pivotal Phase 3 LUCIDITY trial of avexitide for post-bariatric hypoglycemia has been randomized and dosed, marking full enrollment. See our latest analysis for Amylyx Pharmaceuticals. With the shares recently at $13.55, Amylyx has a 1-day share price return of 0.59%, a 30-day share price decline of 10.68%, and a 1-year total shareholder return of 282.77%. The 3-year total shareholder return...

Earlier in March, Marvell Technology announced a quarterly dividend of US$0.06 per share payable on April 30, 2026, and unveiled new Structera S 60260 PCIe 6.0 and S 30260 CXL switches aimed at boosting bandwidth, memory pooling and efficiency in AI data centers. By combining XConn Technologies’ high-radix switching with its existing CXL, PCIe and optical portfolios, Marvell is building an end-to-end interconnect fabric designed to support increasingly memory-hungry AI workloads while giving...

Why American Public Education is on investors’ radar today American Public Education (APEI) is drawing attention after recent trading data highlighted strong momentum in its share price over the past month and past 3 months, prompting fresh interest in its fundamentals. See our latest analysis for American Public Education. At a share price of $57.24, American Public Education has seen strong recent momentum, with a 30 day share price return of 24.92% and a 1 year total shareholder return of...

The healthcare digital payment market is experiencing rapid growth, driven by the increasing use of digital healthcare services, a shift towards cashless transactions, and the adoption of mobile banking. Projections indicate the market will expand significantly from $23.01 billion in 2025 to $62.72 billion by 2030. Key opportunities lie in expanding telemedicine payments, leveraging AI for fraud detection, and enhancing payment security, particularly in the Asia-Pacific region. The global...

Wondering whether CVS Health at around US$70 still offers value, or if the easy money has already been made? This article walks through the key numbers so you can judge for yourself. The stock is around US$70.08 after a 1.7% decline over the past week and double digit declines of 12.3% for the past month and 12.5% year to date, even though the 1 year return sits at 7.4% and the 3 and 5 year returns are 3.4% and 10.0% respectively. Recent headlines around CVS Health have focused on its role...